Two recent genome-wide association studies (GWAS) of risk of glioma in European populations did not identify an association between the XRCC4 rs1805377 and LIG4 rs1805388 polymorphisms and glioma risk[36,37]. This evidence concerns the gene LIG4 and central nervous system cancer.